BTCY Stock Overview
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Biotricity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.79 |
| 52 Week High | US$3.35 |
| 52 Week Low | US$0.40 |
| Beta | 2.43 |
| 1 Month Change | 9.85% |
| 3 Month Change | -22.77% |
| 1 Year Change | -74.43% |
| 3 Year Change | -58.87% |
| 5 Year Change | -80.83% |
| Change since IPO | -70.28% |
Recent News & Updates
Shareholder Returns
| BTCY | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -0.3% | 2.6% | 1.6% |
| 1Y | -74.4% | -31.7% | -10.8% |
Return vs Industry: BTCY underperformed the US Healthcare Services industry which returned -31.7% over the past year.
Return vs Market: BTCY underperformed the US Market which returned -10.8% over the past year.
Price Volatility
| BTCY volatility | |
|---|---|
| BTCY Average Weekly Movement | 15.0% |
| Healthcare Services Industry Average Movement | 10.3% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: BTCY is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.
Volatility Over Time: BTCY's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 44 | Waqaas Al-Siddiq | https://www.biotricity.com |
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components.
Biotricity, Inc. Fundamentals Summary
| BTCY fundamental statistics | |
|---|---|
| Market Cap | US$41.08m |
| Earnings (TTM) | -US$23.25m |
| Revenue (TTM) | US$8.52m |
4.8x
P/S Ratio-1.8x
P/E RatioIs BTCY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BTCY income statement (TTM) | |
|---|---|
| Revenue | US$8.52m |
| Cost of Revenue | US$3.75m |
| Gross Profit | US$4.77m |
| Other Expenses | US$28.02m |
| Earnings | -US$23.25m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.45 |
| Gross Margin | 56.02% |
| Net Profit Margin | -273.05% |
| Debt/Equity Ratio | -138.3% |
How did BTCY perform over the long term?
See historical performance and comparison